Detection of prodromal Parkinson’s disease using a urine proteomics panel and machine learning

Author:

Hällqvist JennyORCID,Schreglmann Sebastian R.ORCID,Kulcsarova KristinaORCID,Skorvanek MatejORCID,Feketeova EvaORCID,Rizig MieORCID,Mollenhauer BritORCID,Turano PaolaORCID,Bacalini Maria GiuliaORCID,Francheschi Claudio,Wood NicholasORCID,Bhatia Kailash P.ORCID,Mills KevinORCID

Abstract

AbstractParkinson’s disease is a progressive neurodegenerative disorder and idiopathic REM-sleep behaviour disorder (iRBD) has been identified as its single most specific early symptom. To facilitate the screening of individuals at high risk to develop Parkinson’s disease, we developed a multiplexed panel of urine proteomics using machine learning and targeted mass spectrometry to detect iRBD. Random urine samples from clinically and genetically well characterized patients with iRBD, idiopathic and hereditary forms of Parkinson’s disease, and matching controls, collected in two academic centres, were analysed in a standardized way.First, a biomarker discovery and exploratory comparison of samples from randomly selected idiopathic Parkinson’s patients and age/sex-matched healthy controls were proteomically profiled and quantified (> 2500 proteins). The most differentially expressed biomarkers were combined into a high-throughput, multiplexed assay using targeted proteomics designed for use of tandem mass spectrometers for potential translation into clinical practise. This was then validated on independent patient and control samples (n=184). After detecting a major influence of sex on the proteome, we focused subsequent analyses on the larger group of available male samples (n= 114) and report results based on iRBD (n= 14), idiopathic (n= 35) and young-onset Parkinson’s disease (n= 15), carriers of LRRK2 (n= 10), PARKIN-gene mutations (n= 5), and healthy control subjects (n= 35). After establishing excellent compatibility between the two study sites, orthogonal partial least squares discriminant analysis (OPLS-DA) excluded a relevant effect of aging, but detected significant differences between iRBD and healthy controls (ANOVA-CVP= 0.002), as well as the combination of iPD/iRBD and healthy controls (ANOVA-CVP= 0.01).Uni- and multivariate analyses detected a shared expression pattern for the protein biomarkers UBC, NCAM1, MIEN1, SPP2, REG1B, ITIH2, BCHE and C3 between iRBD and idiopathic Parkinson’s disease. Utilizing split train/test-datasets in a multiple-regression classifier model resulted in a mean accuracy of 78% to detect iRBD, matching iRBD’s conversion rate to Parkinson’s disease. Hierarchical clustering revealed greater similarities in urine proteomic changes between iRBD and idiopathic than monogenic Parkinson’s disease. Several proteins identified correlated either with clinical severity (e.g. VCAM1, MSN, HPX), or risk for future conversion to Parkinson’s disease (VCAM1, MSN, MYO10, HSPAIL).This demonstrates the power of machine learning and urine biomarkers to identify iRBD patients. As we develop new therapies and interventions, the ability to detect individuals at-risk of neurodegeneration in very early disease stage will be invaluable for treatment success.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3